EUVIMEDEUVIMED entdecken
Systematische Übersicht

Cure after surgery for hepato-pancreato-biliary cancers: A systematic review

Marianna Maspero, Carlo Sposito, Vincenzo Mazzaferro, Giorgio Ercolani, Alessandro Cucchetti

Digestive and Liver Disease · 2025

DOI: 10.1016/j.dld.2024.06.021 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Digestive and Liver Disease, 2025. Verfasst von Marianna Maspero und 4 weiteren Autor:innen. Beteiligte Einrichtung: HPB and Liver Transplantation Unit, Fondazione, IRCCS Istituto Nazionale Tumori, Milan, Italy; Department of Oncology and Hemato-Oncology, University…. Hauptthemen laut MEDLINE: Liver Neoplasms, Biliary Tract Neoplasms, Pancreatic Neoplasms, Hepatectomy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Patients undergoing curative-intent surgery for hepato-pancreato-biliary (HPB) malignancies may achieve statistical cure i.e., a mortality risk which aligns with the general population. AIMS: To summarize the results of different cure models in HPB malignancies. METHODS: We conducted a systematic literature search and selected studies on curative-intent surgery (hepatic resection, HR, or liver transplantation, LT) for HPB malignancies including a cure model in their analysis. The review protocol was registered in PROSPERO (CRD42024528694). RESULTS: Eleven studies reporting a cure model after HPB surgery for malignancy were included: 6 on hepatocellular carcinoma (HCC) two on biliary tract cancers (BTC), one on pancreatic neuroendocrine tumors (pNET), one on pancreatic ductal adenocarcinoma (PDAC), and one on colorectal liver metastases (CRLM). In terms of OS, the cure fraction of HCC is 63.4 %-75.8 % with LT and 31.8 %-40.5 % with HR, achieved within 7.2-10 years and 7-14.4 years respectively. The cure fraction of intrahepatic cholangiocarcinoma is 9.7 % in terms of DFS, but largely depends on tumor stage. PDAC and pNET display a cure fraction of 20.4 % and 57.1 % respectively in terms of DFS, confirming the impact of histotype on DFS. CONCLUSION: Statistical cure for hepato-pancreato-biliary cancers can be achieved with surgery. The probability of cure depends on the interplay between tumor stage and aggressiveness, effectiveness of the surgical treatment and persistence of chronic conditions after surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsBiliary Tract NeoplasmsPancreatic NeoplasmsHepatectomyHumansCarcinoma, HepatocellularLiver TransplantationCholangiocarcinomaCarcinoma, Pancreatic Ductal

Autor:innen und Institutionen

  • HPB and Liver Transplantation Unit, Fondazione, IRCCS Istituto Nazionale Tumori, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Italy.
  • Department of Medical and Surgical Sciences - DIMEC, Alma Mater Studiorum - University of Bologna, Bologna, Italy; Morgagni, Pierantoni Hospital, Forlì, Italy.
  • Department of Medical and Surgical Sciences - DIMEC, Alma Mater Studiorum - University of Bologna, Bologna, Italy; Morgagni, Pierantoni Hospital, Forlì, Italy. Electronic address: alessandro.cucchett2@unibo.it.

Zitieren

APA

Maspero, M., Sposito, C., Mazzaferro, V., Ercolani, G., & Cucchetti, A. (2025). Cure after surgery for hepato-pancreato-biliary cancers: A systematic review. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2024.06.021

Vancouver

Maspero M, Sposito C, Mazzaferro V, Ercolani G, Cucchetti A. Cure after surgery for hepato-pancreato-biliary cancers: A systematic review. Digestive and Liver Disease. 2025. doi:10.1016/j.dld.2024.06.021

BibTeX
@article{Maspero2025,
  author = {Maspero, Marianna and Sposito, Carlo and Mazzaferro, Vincenzo and Ercolani, Giorgio and Cucchetti, Alessandro},
  title = {Cure after surgery for hepato-pancreato-biliary cancers: A systematic review},
  journal = {Digestive and Liver Disease},
  year = {2025},
  doi = {10.1016/j.dld.2024.06.021}
}
Kostenlos starten →